Tg Therapeutics TGTX
NASDAQ TGTX
$53.62 -2.16 (-3.87%)
As of: Oct 1, 2026 · 3:59 PM EDT

Tg Therapeutics (TGTX) Long-Term Deferred Tax (2025 - 2026)

Updated

Tg Therapeutics (TGTX) reported Long-Term Deferred Tax of $343.43 million for Q2 2026, down 0.2% from the prior quarter.

Analysis

Tg Therapeutics (TGTX) Long-Term Deferred Tax (2025 - 2026) Analysis & Trends

At the end of FY2025, Tg Therapeutics posted Long-Term Deferred Tax of $348 million.

  • Per Business Quant data, the three quarters before Q2 2026 came in at $344.14 million (Q1 2026), $348 million (Q4 2025) and $366.63 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Tg Therapeutics 8.54 Bn 7.93 Bn 199.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 343.43 Mn
Mar 31, 2026 344.14 Mn
Dec 31, 2025 348.00 Mn
Sep 30, 2025 366.63 Mn
API Access

Tg Therapeutics Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=TGTX&period=max&api_key=YOUR_API_KEY